Abstract
We report a potential pitfall of 123I-metaiodobenzylguanine (MIBG) scan. Magnetic resonance imaging performed for other reasons, showed 2.5 cm tumor in the left adrenal gland. On questioning patient had episodic palpitations, flushing and hypertension suggestive of pheochromocytoma. Urinary metanephrine level was of borderline value but serum chromogranin A level was clearly elevated. 123I-MIBG scan showed accumulation of the tracer in the upper left abdomen and the finding was suspected to be intra-adrenal pheochromocytoma. During operation two separate tumors, adrenocortical adenoma in the left adrenal gland, and another smaller, extra-adrenal paraganglioma locating very close to the adenoma, were found. Thus the positive MIBG finding was caused by a paraganglioma with the concurrent presentation of nonfunctioning adrenocortical adenoma.
Key words
Pheochromocytoma - paraganglioma - MIBG scan
References
-
1
Bahar R H, Mahmoud S, Ibrahim A, al-Gazzar A H.
A false positive I-131 MIBG due to dilated renal pelvis: a case report.
Clin Nucl Med.
1988;
13
900-902
-
2
Bathmann J, Neumann H P, Sigmund G, Moser E.
False-positive diagnosis of a pheochromocytoma with I-123 metaiodobenzylguanidine.
Clin Nucl Med.
1994;
19
221-223
-
3
Berglund A S, Hulthen U L, Manhem P, Thorsson O, Wollmer P, Törsnquist C.
Metaiodobenzylguanidine (MIBG) scintigraphy and computed tomography (CT) in clinical practice. Primary and secondary evaluation for localization of phaeochromocytomas.
J Intern Med.
2001;
249
247-251
-
4
Burt M G, Allen B, Conaglen J V.
False positive 131I - metaiodobenzylguanidine scan in the postoperative assessment of malignant phaeochromocytoma secondary to medullary hyperplasia.
N Z Med J.
2002;
115
18
-
5
Chatal J, Chardonnel B.
Comparison of iodobenzylguanidine imaging with computed tomography in locating pheochromocytoma.
J Clin Endocrinol Metab.
1985;
769-772
-
6
Cortes-Blanco A, Martinez-Lazaaro R, Martinez-Duncker C.
Unusual diffuse [131]MIBG accumulation in a kidney with renal artery stenosis.
Nephrol Dial Transplant.
2000;
15
1885-1886
-
7
Feggi L, Uberti E, Pansini G, Transforini G, Prandini N, Ambrosio M, D'Urso A, Faggioli R.
Pitfalls in scintigraphic detection of neuroendocrine tumors.
Eur J Nucl Med.
1992;
19
214-218
-
8
Fischer M, Vetter W, Winterberg B, Vetter H.
131I - metaiodobenzylguanidine - a new agent for scintigraphic imaging and treatment of pheochromocytoma.
Nuklearmedizin.
1984;
23
77-79
-
9
Gallar P, Oliet A, Hernandez E, Vigil A, Ortega O.
Renal failure as a cause of false-positive results on metaiodobenzulguanidine scan.
Nephrol Dial Transplant.
1993;
8
481
-
10
Hanson M, Feldman J, Beam C, Leight G, Coleman R.
Iodine-131-metaiodobenzylguanidine scintigraphy and biochemical analysis in suspected pheochromocytoma.
Arch Intern Med.
1991;
151
1397-1402
-
11
Horne T, Glaser B, Krausz Y, Rubinger D, Britton K E.
Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue.
Clin Nucl Med.
1991;
16
239-242
-
12
Houghton A, Clarke S, Jourdan M.
False positive diagnosis of adrenal phaechromocytoma on metaiodobenzylquanidine scan.
Br J Clin Pharmacol.
1990;
44
411-412
-
13
Izumi M, Kakezono F, Nagayama S, Kiriyama T, Yokoyama N, Yamashita S, Morita S, Hirayu H, Kubo I, Ohtakara S.
Clinical applications of 131 I-metaiodobenzylguoanidine scintigraphy in Japan (Japanese, English abstract).
Kakuigaku (Nucl Med).
1986;
23
145-152
-
14
Jacobs A, Lenoir P, Delree M, Ramet J, Piepsz A.
Unusual 99 mTc-MDP and 123I - MIBG images in focal pyelonephritis.
Clin Nucl Med.
1990;
15
821-824
-
15
Kao P F, Tzen K Y, Huang M J, You D L.
Obstructive hydronephrosis with I-131 MIBG accumulation mimicking huge pheochromocytoma: a diagnostic pitfall found with Tc-99 m MDP imaging.
Clin Nucl Med.
1996;
21
994-995
-
16
Krubsack A J, Arnaout M A, Hagen Zielonka T CJS, Choi H Y, Akhtar R, Schulte W J.
Zona fasciculata cortical adenoma and adrenal medullary hyperplasia in MEN II patient: unique concurrent presentation.
Clin Nucl Med.
1988;
13
730-733
-
17
Kloos R, Gross M, Francis I, Korobkin M, Shapiro B.
Incidentally discovered adrenal masses.
Endocr Rev.
1995;
16
460-484
-
18 Kloos R T, Khafagi F, Gross M D, Shapiro B. Adrenal. Maisey MN, Britton KE, Collier BD, Siraj QH Clinical Nuclear Medicine. 3rd ed. London, New York, Tokyo, Melbourne, Madras; Chapman & Hall Medical 1998: 371-380
-
19
Letizia C, De Toma G, Massa R, Corsi A, Caliumi C, Subioli S, D'Erasmo E.
False-positive diagnosis of adrenal pheochromocytoma on iodine-123-MIBG scan.
J Endocrinol Invest.
1998;
21
779-783
-
20
Rainis T, Ben-Haim S, Dickstein G.
False positive metaiodobenzylguanidine scan in a patient with a huge adrenocortical carcinoma.
J Clin Endocrinol Metab.
2000;
85
5-7
-
21
Shapiro B, Sisson J C, Eyre P, Copp J E, Dmuchowski C, Beierwaltes W H.
131I - MIBG - a new agent in diagnosis and treatment of pheochromocytoma.
Cardiology.
1985 a;
1
137-142
-
22
Shapiro B, Copp J E, Sisson J C, Eyre P L, Wallis J, Beierwaltes W H.
Iodine-131 metaiodobenzylguanidine for the locating of suspected pheochromocytoma: experience in 400 cases.
J Nucl Med.
1985 b;
26
576-585
-
23
Sone H, Okuda Y, Nakamura Y, Ishikawa N, Yamaoka T, Kawakami Y, Odawara M, Matsushima T, Kawai K, Yamashita K.
Radioiodinated metaiodobenzylguanidine scintigraphy for pheochromocytoma. A false-positive case of adrenocortical adenoma and literature review.
Horm Res.
1996;
46
138-142
-
24
Tormey W P, Keeling F, Lee M J.
123I - metaiodobenzylguanidine scans in phaeochromocytoma diagnosis: current clinical practice and relationship to biochemical screening.
Int J Clin Pract.
1999;
53
428-432
-
25
Troncone L, Rufini V, Montemaggi P, Danza F M, Lasorella A, Mastrangelo R.
The diagnostic and therapeutic utility of radioiodinated metaiodobenzylguanidine (MIBG). 5 years of experience.
Eur J Nucl Med.
1990;
16
325-335
-
26
Ünal S N, Adalet I, Mudun A, Terzioglu T, Alagol F, Agan Cantez M S.
False-positive uptake of I-131 MIBG.
Clin Nucl Med.
1995;
20
1096-1097
M. D. Päivi Kekäläinen
Department of Medicine, Joensuu Central Hospital
Tikkamäentie 16
80210 Joensuu
Finland
Phone: + 358171713040
Fax: + 35 81 31 71 30 06
Email: paivi.kekalainen@pkshp.fi